MetaCap

Turn Therapeutics Earnings

NASDAQ: TTRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.10-0.545 (-6.31%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Turn Therapeutics earnings summary

In its most recent report on Nov 12, 2026 (Sep/2026), TTRX posted EPS of $-0.21. Quarterly EPS is down 2200.0% from the same quarter a year earlier. Across the last 6 reports, TTRX shares moved an average of 12.1% (in either direction) in the first trading session after results, rising 1 times and falling 4 times.

Summary generated from market data by MetaCap's automated system. Methodology

TTRX earnings history

Turn Therapeutics reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 12, 2026—$-0.21—-13.4%
Nov 9, 2026—$-0.21—-13.4%
Aug 12, 2026—$-0.20—-1.1%
May 11, 2026—$-0.03—+26.7%
Mar 31, 2026—$0.01—0.0%
Nov 13, 2025—$-0.07—-18.3%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related